Symposium on Muscle-Bone Interaction in Duchenne Muscular Dystrophy 2019

21 June 2019

This symposium organised by the University of Glasgow and Newcastle University with support from Duchenne Parent Project Nl and Parent Project Muscular Dystrophy is a scientific educational forum as a follow-up initiative of the recent European Neuromuscular Centre workshop on developing osteoporosis clinical trials in DMD (June 2018). The symposium will focus on the main aspects:

1- Update on muscle and bone as endocrine organs
2- Extent of osteoporosis in DMD and implementation of the updated bone & endocrine international standards of care (2018)
3- New bone therapeutic agents in DMD and glucocorticoid-induced osteoporosis
4- Investigative agents in DMD trials and impact on skeletal development
5- The path forward to gathering evidence of bone protective therapy in DMD

Further details of this symposium are available on the website http://www.gla.ac.uk/mmbone-dmd2019 or email jarod.wong@glasgow.ac.uk. Registration will open by early January 2019. We strongly encourage paediatric and adult neurologists, neuromuscular specialists, endocrinologists and clinicians with an interest for bone health to attend this symposium to participate in discussions relating to gathering evidence, developing research and shaping clinical care.

This symposium has been adopted as a satellite symposium to the International Conference for Children’s Bone Health held in Salzburg, 22nd-25th June 2019, www.iccbh.org

Dr Jarod Wong (University of Glasgow, UK) and Dr Michela Guglieri (Newcastle University, UK)

Venue

St Virgil Conference Centre, Salzburg, Austria

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern